Cirrhosis reversal: a duel between dogma and myth - PubMed (original) (raw)

Review

Cirrhosis reversal: a duel between dogma and myth

Valeer J Desmet et al. J Hepatol. 2004 May.

No abstract available

PubMed Disclaimer

Similar articles

• Comments on cirrhosis reversal.
  Desmet VJ. Desmet VJ. Dig Liver Dis. 2005 Dec;37(12):909-16. doi: 10.1016/j.dld.2005.08.007. Epub 2005 Oct 6. Dig Liver Dis. 2005. PMID: 16213802 Review. No abstract available.
• [Electron microscopic findings in liver cirrhosis].
  Cossel L. Cossel L. Dtsch Z Verdau Stoffwechselkr. 1967 Dec;27(5):157-66. Dtsch Z Verdau Stoffwechselkr. 1967. PMID: 5595737 German. No abstract available.
• Current concepts in cirrhosis.
  Popper H, Orr W. Popper H, et al. Scand J Gastroenterol Suppl. 1970;6:203-22. Scand J Gastroenterol Suppl. 1970. PMID: 4917497 Review. No abstract available.
• Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood.
  Bortolotti F, Guido M, Cadrobbi P, Crivellaro C, Bartolacci S, Rugge M, Gatta A. Bortolotti F, et al. Dig Liver Dis. 2005 Dec;37(12):964-7. doi: 10.1016/j.dld.2005.04.030. Epub 2005 Oct 24. Dig Liver Dis. 2005. PMID: 16249128
• Advances in the pathogenesis of liver cirrhosis.
  Castilla Cortázar A. Castilla Cortázar A. Rev Med Univ Navarra. 1993 Apr-Jun;38(2):51-7. Rev Med Univ Navarra. 1993. PMID: 14735723 Review. No abstract available.

Cited by

• Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease.
  Krassenburg LAP, Maan R, Puenpatom A, Erler NS, Welsch C, van Hees S, Cerrhoci O, Vermehren J, de Knegt RJ, Hansen BE, Zeuzem S, Vanwolleghem T, Janssen HLA, de Man RA, Feld JJ, van der Meer AJ. Krassenburg LAP, et al. BMJ Open Gastroenterol. 2023 Dec 7;10(1):e001209. doi: 10.1136/bmjgast-2023-001209. BMJ Open Gastroenterol. 2023. PMID: 38637963 Free PMC article.
• Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis?
  van Doorn DJ, Holleboom AG, Takkenberg RB, Verheij J, Lantinga MA. van Doorn DJ, et al. Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):912-915. doi: 10.21037/hbsn-23-445. Epub 2023 Oct 30. Hepatobiliary Surg Nutr. 2023. PMID: 38115935 Free PMC article. No abstract available.
• Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach.
  Brennan PN, Elsharkawy AM, Kendall TJ, Loomba R, Mann DA, Fallowfield JA. Brennan PN, et al. Nat Rev Gastroenterol Hepatol. 2023 Oct;20(10):679-688. doi: 10.1038/s41575-023-00796-x. Epub 2023 Jun 2. Nat Rev Gastroenterol Hepatol. 2023. PMID: 37268740 Free PMC article. Review.
• Multidisciplinary intensive lifestyle intervention improves markers of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity: a retrospective matched-cohort study.
  Tomah S, Salah T, Al-Badri M, Dhaver S, Gardner H, Tasabehji MW, Hamdy O. Tomah S, et al. Clin Diabetes Endocrinol. 2023 Apr 12;9(1):3. doi: 10.1186/s40842-023-00150-9. Clin Diabetes Endocrinol. 2023. PMID: 37046323 Free PMC article.
• Genetic Polymorphism in Angiotensinogen and Its Association with Cardiometabolic Diseases.
  Shahid M, Rehman K, Akash MSH, Suhail S, Kamal S, Imran M, Assiri MA. Shahid M, et al. Metabolites. 2022 Dec 19;12(12):1291. doi: 10.3390/metabo12121291. Metabolites. 2022. PMID: 36557328 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information